
|Videos|July 3, 2015
What is the Future of Biosimilars?
Author(s)Davy James, Managing Editor
CEO of Avella Specialty Pharmacy Rebecca M. Shanahan, Esq., discusses how specialty pharmacies can best manage the rising cost of specialty drugs to improve outcomes for patients.
Advertisement
CEO of Avella Specialty Pharmacy Rebecca M. Shanahan, Esq., discusses how specialty pharmacies can best manage the rising cost of specialty drugs to improve outcomes for patients.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Newly Approved Specialty Drugs Advance Care for Inflammatory and Autoimmune Diseases
2
Measles On the Rise: Global Surge and US Status at Risk
3
November 2025 Trending Products
4
Data Suggest Routine Multicancer Early Detection Tests Could Reduce Late–Stage Diagnoses
5















































































































































































































